Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

Pan-European Retail Sales figures from December are due early Thursday. Median market forecasts expect an upswing to 1.9% YoY ...

The Japanese Yen (JPY) is one of the world’s most traded currencies. Its value is broadly determined by the performance of the Japanese economy, but more specifically by the Bank of Japan’s policy, ...

Experts at the 2025 Clinical Trial Supply Europe will explore supply chain challenges and the impact of AI on trials.

The outlook for rare earths is supported by strong supply and demand fundamentals as the world heads into a new economic era ...

Immunotherapy has shown a 27% reduction in mortality for patients with limited-stage small cell lung cancer, based on Phase ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly® in Europe), has been officially approved by the European Commission (EC) ...

Pheasants Forever will hold a meeting at 7 p.m. on Tuesday, Feb. 11, at Lazy Jack's, 6735 Fairgrounds Road NW, to discuss ...

Detailed price information for AI / ML Innovations Inc (AIMLF) from The Globe and Mail including charting and trades.

In addition to the presentations, Medicenna’s management team will be available for one-on-one meetings with investors at both conferences. Investors interested in scheduling a meeting can contact ...

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

The patent application, filed under Application Number N2039644, represents a significant step forward in the Company's intellectual property strategy. This milestone highlights Cosmos Health's ...